PATENT CLAIM ANALYSIS

Application Number: 16244956
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "317000"]

Abstract:
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.

Claim (Index 21):
The pharmaceutical composition of  claim 18 , wherein the pharmaceutically acceptable carrier is microcrystalline cellulose.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 99.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15586531', '12617838', '13632588', '14060846', '15685119']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8139360413230213
- 35 USC 102 Novelty (BERT): 0.5668717537198585
- Combined Prediction Score: 0.7892296125627051
- Mean Citation Score: 450.982426
- Max Citation Score: 482.89838
- Similarity Product: 315.21696193606493

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test